Investing News

Vertex, CRISPR Therapeutics Get FDA Approval for First CRISPR Gene-Editing Therapy in US

Vertex Pharmaceuticals and CRISPR Therapeutics received regulatory approval for the first gene-editing therapy using CRISPR technology in the U.S.

Articles You May Like

The Future of Fintech
How to Convert to a Roth IRA
Who Offers IRA Accounts With No Minimum Deposit?
3 Flying Car Stocks to Watch Now: May 2024 
Forever Stocks: 3 Dividend Kings Reigning Supreme for 50+ Years